Accuracy of genotyping of single-nucleotide polymorphisms by PCR-ELISA allele-specific oligonucleotide hybridization typing and by amplification refractory mutation system.

References 1. Aoshima H, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Inoue T. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998;22: 73–8. 2. Gundberg CM, Markowitz ME, Mizruchi M, Rosen JF. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985;60:736–9. 3. Greenspan SL, Dresner-Pollak R, Parker RA, Londo D, Ferguson L. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 1997;60:419–23. 4. Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int 1998;63:102–6. 5. Hassanger C, Risteli J, Risteli L, Jensen SB, Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992;7:1307–11. 6. Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C. Measurements of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I. J Bone Miner Res 1998;12:1–7. 7. Nakayama H, Yano T, Sagara Y, Ando K, Kasai Y, Taketani Y. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism. Endocr J 1997;44:497–84. 8. Fledelius C, Kolding I, Qvist P, Bonde M, Hassanger C, Reginster JY, et al. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide a1-chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA. Scand J Clin Lab Investig 1997;57:73–83. 9. Halberg F. Chronobiology. Annu Rev Physiol 1969;31:675–725. 10. Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, et al. Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptide. Clin Chem 1998;44:2290–3000. 11. Ju HSJ, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:1570–6. 12. Schlemmer A, Hassanger C, Jensen SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992;74:476–80. 13. Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NSJ, Cain FC. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998;83:3930–5.